medigraphic.com
ISSN 0016-3813 (Print)

2004, Number S3

<< Back Next >>

Gac Med Mex 2004; 140 (S3)

VIII. Bacterial pollution of the blood components

Quintana-González S

Language: Spanish
References: 10
Page: 90-94
PDF size: 44.75 Kb.


Text Extraction

No abstract


REFERENCES

  1. Fantus B. Landmask Article July 10, 1093: Therapy of the Cook County Hospital By Bernard Fautus. JAMA 1984:251:647-9.

  2. Murphy WG, Smyth J. Testing for bacteria in platelet concentrates: defining the parameters. Transf Apher Science 2001;24:347-349.

  3. Depcik-Smith ND, Hay SN, Brecher ME. Bacterial contamination of blood products: Factors, options, and insights. J Clin Apher 2001;16:192-201.

  4. Wagner SJ. Transfusion transmitted bacterial infection: risks, sources and interventions. Vox Sang 2004;86:157-163.

  5. Hillyer CD, Josephson CD, Blajchman MA, Vostal JG, Epstein JS, Goodman JL. Bacterial contamination of blood components: Risks, strategies, and regulation. Joint ASH and AABB educational session in transfusion medicine. Hematology 2003:575-589.

  6. Blajchman MA, Goldman M, Baeza F. Improving the bacteriological safety of platelet transfusions. Transf Med Rev 2004;18:11-24.

  7. Lee CK, Ho PL, Chan NK, Hong J, Lin CK. Impact of donor arm skin disinfection on the bacterial contamination rate of platelet concentrates. Vox Sang 2002;83:204-208.

  8. McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara AJ. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004;86:178-182.

  9. Ness PM, Braine HG, King K. single donor platelets reduce the risk of septic transfusion reaction. Transfusion 2001;41:857-861.

  10. Bell CF, Botteman MF, Xin Gao, Weissfeld JL, Postma MJ, Pashos CL, Triulzi D, and Staginnus U. Cost-effectiveness of Transfusion of Platelet components prepared with pathogen inactivation treatment in the United States. Clinical Therapeutics. 2003:2464-2486.




2020     |     www.medigraphic.com